Description

Duspatalin Coated Tablets 135 mg. №15

Ingredients:

Each coated tablet contains 135 mg of Mebeverine Hydrochloride.

Dosage:

The usual dose for adults is one tablet three times a day, preferably before meals.

Indications:

Duspatalin tablets are indicated for the treatment of irritable bowel syndrome (IBS) and related gastrointestinal disorders.

Contraindications:

Do not use Duspatalin if you are allergic to Mebeverine Hydrochloride or any other ingredients in the tablets.

Directions:

Swallow the tablets whole with a glass of water. Do not crush or chew the tablets.

Scientific Evidence:

Mebeverine, the active ingredient in Duspatalin, acts as a musculotropic antispasmodic agent that directly affects the smooth muscle in the gastrointestinal tract. Studies have shown that Mebeverine helps reduce the frequency and intensity of abdominal pain, bloating, and discomfort associated with IBS.

Additional Information:

Duspatalin coated tablets have been well-tolerated in clinical trials with minimal side effects reported. It is considered a first-line treatment for IBS due to its effectiveness in relieving symptoms and improving quality of life for patients.

Compared to other antispasmodic agents, Duspatalin has shown similar efficacy but with a lower risk of adverse effects, making it a preferred choice for many healthcare providers.